Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

Palbociclib showed limited activity in histology-agnostic CDK4- or CDK6-amplified tumors, although central nervous system tumors may be worthy of future investigation.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2024-10-22
DOI
https://doi.org/10.1158/1078-0432.ccr-24-0036
Citations
4
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
1.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

Angela M. DeMichele, Lyndsay N. Harris, Keith T. Flaherty, Peter James O'Dwyer et al.
4 citations
Clinical Cancer Research
Advanced Breast Cancer Therapies
1.68
article

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

Angela M. DeMichele, Lyndsay N. Harris, Keith T. Flaherty, Peter James O'Dwyer, Larry Rubinstein, David R. Patton, Lisa M. McShane, Mark H. O’Hara, Mark A. Dickson, Carlos L. Arteaga, Alice P. Chen, Richard Piekarz, Barbara A. Conley, James V. Tricoli, Robert J. Gray, Stanley R. Hamilton, Opeyemi A. Jegede, P. Mickey Williams, Adedayo A. Onitilo, Victoria Wang
article en
4 citations

Abstract

Palbociclib showed limited activity in histology-agnostic CDK4- or CDK6-amplified tumors, although central nervous system tumors may be worthy of future investigation.

Clinical Cancer ResearchVol. 31(1)
National Institutes of Health (US), City Of Hope National Medical Center (US), Memorial Sloan Kettering Cancer Center (US), Cornell University (US), Kettering University (US), Massachusetts General Hospital (US), ECOG-ACRIN Cancer Research Group (US), City of Hope (US), Marshfield Clinic Weston Center (US), Dana-Farber Cancer Institute (US), National Cancer Institute (UA), Frederick National Laboratory for Cancer Research (US), National Cancer Institute (MY), National Cancer Institute (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US)
American College of Radiology Imaging Network, Margaret A. Cargill Foundation, ECOG-ACRIN Cancer Research Group, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 15%
Advanced Breast Cancer Therapies
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.